• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类疟原虫恶性疟原虫对周效磺胺的耐药性由二氢蝶酸合酶的突变以及与叶酸利用相关的另一个因素决定。

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.

作者信息

Wang P, Read M, Sims P F, Hyde J E

机构信息

Department of Biochemistry and Applied Molecular Biology, University of Manchester Institute of Science and Technology (UMIST), UK.

出版信息

Mol Microbiol. 1997 Mar;23(5):979-86. doi: 10.1046/j.1365-2958.1997.2821646.x.

DOI:10.1046/j.1365-2958.1997.2821646.x
PMID:9076734
Abstract

Sulfadoxine/pyrimethamine (Fansidar) is widely used in Africa for treating chloroquine-resistant falciparum malaria. To clarify how parasite resistance to this combination arises, various lines of Plasmodium falciparum were used to investigate the role of naturally occurring mutations in the target enzyme, dihydropteroate synthetase (DHPS), in the parasite response to sulfadoxine inhibition. An improved drug assay was employed to identify a clear correlation between sulfadoxine-resistance levels and the number of DHPS mutations. Moreover, tight linkage was observed between DHPS mutations and high-level resistance in the 16 progeny of a genetic cross between sulfadoxine-sensitive (HB3) and sulfadoxine-resistant (Dd2) parents. However, we also demonstrate a profound influence of exogenous folate on IC50 values, which, under physiological conditions, may have a major role in determining resistance levels. Importantly, this phenotype does not segregate with dhps genotypes in the cross, but shows complete linkage to the two alleles of the dihydrofolate reductase (dhfr) gene inherited from the parental lines. However, in unrelated lines, this folate effect correlates less well with DHFR sequence, indicating that the gene responsible may be closely linked to dhfr, rather than dhfr itself. These results have major implications for the acquisition of Fansidar resistance by malaria parasites.

摘要

周效磺胺/乙胺嘧啶(法西达)在非洲被广泛用于治疗对氯喹耐药的恶性疟。为阐明疟原虫对这种联合用药的耐药性是如何产生的,研究人员使用了多种恶性疟原虫株来探究目标酶二氢蝶酸合酶(DHPS)中自然发生的突变在疟原虫对周效磺胺抑制反应中的作用。采用了一种改进的药物检测方法来确定周效磺胺耐药水平与DHPS突变数量之间的明确关联。此外,在周效磺胺敏感(HB3)和耐药(Dd2)亲本之间的遗传杂交产生的16个后代中,观察到DHPS突变与高水平耐药之间存在紧密连锁。然而,我们还证明了外源性叶酸对半数抑制浓度(IC50)值有深远影响,在生理条件下,这可能在决定耐药水平方面起主要作用。重要的是,这种表型在杂交中并不与dhps基因型分离,而是与从亲本系遗传而来的二氢叶酸还原酶(dhfr)基因的两个等位基因完全连锁。然而,在不相关的株系中,这种叶酸效应与DHFR序列的相关性较差,这表明相关基因可能与dhfr紧密连锁,而不是dhfr本身。这些结果对疟原虫获得法西达耐药性具有重要意义。

相似文献

1
Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.人类疟原虫恶性疟原虫对周效磺胺的耐药性由二氢蝶酸合酶的突变以及与叶酸利用相关的另一个因素决定。
Mol Microbiol. 1997 Mar;23(5):979-86. doi: 10.1046/j.1365-2958.1997.2821646.x.
2
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.恶性疟原虫二氢叶酸还原酶和二氢蝶酸合酶的突变以及乙胺嘧啶-磺胺多辛的使用和耐药性的流行病学模式
J Infect Dis. 1997 Dec;176(6):1590-6. doi: 10.1086/514159.
3
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.在马拉维将磺胺多辛和乙胺嘧啶作为一线治疗药物引入七年之后,恶性疟原虫感染中五重突变的二氢蝶酸合酶/二氢叶酸还原酶基因的高流行率。
Acta Trop. 2003 Mar;85(3):363-73. doi: 10.1016/s0001-706x(02)00264-4.
4
Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.乌干达恶性疟原虫对磺胺多辛/乙胺嘧啶的耐药性:与二氢叶酸还原酶和二氢蝶酸合酶基因多态性的相关性
Am J Trop Med Hyg. 1999 Sep;61(3):463-6. doi: 10.4269/ajtmh.1999.61.463.
5
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.深入了解恶性疟原虫对乙胺嘧啶-磺胺多辛耐药的机制:肯尼亚疟原虫二氢叶酸还原酶和二氢蝶酸合酶的基因分型
Antimicrob Agents Chemother. 2000 Apr;44(4):991-6. doi: 10.1128/AAC.44.4.991-996.2000.
6
Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.恶性疟原虫体外抗叶酸抗性与二氢叶酸还原酶及二氢蝶酸合酶基因突变的关联
J Postgrad Med. 2004 Jan-Mar;50(1):17-20.
7
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.恶性疟原虫二氢叶酸还原酶(dhfr)和二氢蝶酸合成酶(dhps)基因多态性与尼日利亚疟疾感染患者体内与年龄相关的磺胺多辛-乙胺嘧啶耐药性
Acta Trop. 2005 Sep;95(3):183-93. doi: 10.1016/j.actatropica.2005.06.015.
8
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.坦桑尼亚姆林巴恶性疟原虫疟疾对周效磺胺-乙胺嘧啶的耐药性
Malar J. 2006 Oct 31;5:94. doi: 10.1186/1475-2875-5-94.
9
Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.疟原虫寄生虫中对磺胺多辛-乙胺嘧啶产生抗药性的突变的有序积累。
J Infect Dis. 2014 Jan 1;209(1):130-9. doi: 10.1093/infdis/jit415. Epub 2013 Aug 6.
10
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.二氢叶酸还原酶和二氢蝶酸合酶基因突变对恶性疟原虫特征改变的影响
Malar J. 2007 Aug 8;6:108. doi: 10.1186/1475-2875-6-108.

引用本文的文献

1
A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention.了解磺胺多辛-乙胺嘧啶在疟疾化学预防中的应用路线图。
Parasitology. 2025 Feb;152(2):133-142. doi: 10.1017/S0031182025000071.
2
and markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon.以及喀麦隆实施季节性疟疾化学预防五年(2016 - 2020年)后对磺胺多辛-乙胺嘧啶耐药性的标志物。
Wellcome Open Res. 2024 Jun 20;9:323. doi: 10.12688/wellcomeopenres.22347.1. eCollection 2024.
3
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.
2012-2022 年期间西非地区疟原虫分离株中磺胺多辛-乙胺嘧啶耐药相关分子标志物的流行情况。
Sci Rep. 2024 Nov 4;14(1):26567. doi: 10.1038/s41598-024-75828-w.
4
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II genetic cross.在NF54×Cam3.II基因杂交中鉴定药物/代谢物转运体1作为奎宁抗性的标志物。
bioRxiv. 2024 Oct 1:2024.09.27.615529. doi: 10.1101/2024.09.27.615529.
5
A computational method for predicting the most likely evolutionary trajectories in the stepwise accumulation of resistance mutations.一种预测耐药突变逐步积累中最可能进化轨迹的计算方法。
Elife. 2023 Dec 22;12:e84756. doi: 10.7554/eLife.84756.
6
Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.2019 年安哥拉三个地点儿童无并发症恶性疟原虫样本中磺胺多辛-乙胺嘧啶耐药的分子标志物。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0160122. doi: 10.1128/aac.01601-22. Epub 2023 Mar 14.
7
Distinct pattern and prevalence of dihydropteroate synthase gene mutations in children with sickle cell anaemia and haemoglobin AA in Benin City, Nigeria: the impact of HbAA.在尼日利亚贝宁城,镰状细胞贫血和血红蛋白 AA 儿童中二氢叶酸还原酶基因突变的独特模式和流行率:HbAA 的影响。
Pan Afr Med J. 2022 Oct 13;43:80. doi: 10.11604/pamj.2022.43.80.34334. eCollection 2022.
8
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.在三个亚洲国家中,恶性疟原虫抗叶酸和抗磺胺类药物耐药标记物 pfdhfr 和 pfdhps 的十年持续存在和演变。
PLoS One. 2022 Dec 16;17(12):e0278928. doi: 10.1371/journal.pone.0278928. eCollection 2022.
9
Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activity.硫胺类似物作为丙酮酸脱氢酶抑制剂以及具有非硫胺相关抗疟活性的硫胺类似物的发现
RSC Med Chem. 2022 Jun 7;13(7):817-821. doi: 10.1039/d2md00085g. eCollection 2022 Jul 20.
10
Standard Selection Treatments with Sulfadiazine Limit Plasmodium yoelii Host-to-Vector Transmission.标准磺胺嘧啶处理限制约氏疟原虫宿主向媒介的传播。
mSphere. 2022 Jun 29;7(3):e0010622. doi: 10.1128/msphere.00106-22. Epub 2022 May 19.